查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1730971

2025年奥贝胆酸全球市场报告

Obeticholic Acid Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年奥贝胆酸市场规模将快速成长。到 2029 年，这一数字将成长至 16.7 亿美元，复合年增长率为 13.1%。预测期内的增长可归因于原发性胆汁性胆管炎 (PBC) 和非酒精性脂肪性肝炎 (NASH) 盛行率的不断上升、对创新肝病治疗的需求不断增长、对肝病和可用治疗方法的认识不断提高、新兴市场的全球医疗保健服务不断扩大，以及对肝病认识的日益关注。这段时期的主要趋势包括采用 NASH治疗方法、建立伙伴关係并开展进一步开发、整合数位健康工具进行监测和合规、转向非酒精性脂肪肝病 (NAFLD) 治疗、肝病生物标誌物的进步以及诊断技术的进步。

肝病盛行率的上升预计将推动奥贝胆酸市场的成长。肝病是一种损害肝臟功能的疾病。肝病发生率的上升是由于过量摄取会损害肝细胞，导致发炎、肝硬化，最终导致肝功能衰竭。奥贝胆酸透过活化法尼醇X受体（FXR）、减少胆汁酸的累积、减轻发炎、减缓纤维化的进展并改善肝功能，有助于治疗肝病。例如，2024 年 12 月，英国健康改善与差异办公室报告称，酒精性肝病导致的过早死亡人数将增加 3.6%，从 2022 年的 5,776 人达到 2023 年的 5,984 人。肝病患者数的增加正在推动奥贝胆酸市场的发展。

在奥贝胆酸市场营运的公司正在致力于开发 FXR促效剂等创新产品，以改善肝病治疗和患者预后。 FXR促效剂是活化 FXR 的化合物，FXR 是一种参与调节肝臟胆汁酸代谢、发炎和纤维化的受体。这些促效剂用于治疗原发性胆汁性胆管炎（PBC）和非酒精性脂肪性肝炎（NASH）等疾病，并有助于增强肝功能。例如，2024年2月，美国生物製药公司Intercept Pharmaceuticals Inc.宣布，美国食品药物管理局（FDA）已接受其针对PBC治疗药物Ocaliva的补充新药认证申请（sNDA）。 FDA 的批准标誌着向检验奥贝胆酸在治疗 PBC 中的临床效用迈出了一步。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 - 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治以及感染疾病和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球奥贝胆酸PESTEL分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球奥贝胆酸市场：成长率分析
  • 全球奥贝胆酸市场表现：规模与成长，2019-2024
  • 全球奥贝胆酸市场预测：2024-2029 年及 2034 年规模与成长
  • 全球奥贝胆酸总目标市场（TAM）

第六章市场区隔

  • 全球奥贝胆酸市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 锭剂
  • 胶囊
  • 其他产品类型
  • 全球奥贝胆酸市场通路、绩效及预测（2019-2024、2024-2029、2034）
  • 医院药房
  • 零售药局
  • 网路药局
  • 全球奥贝胆酸市场应用、绩效及预测（2019-2024、2024-2029、2034）
  • 原发性胆汁性胆管炎
  • 非酒精性脂肪肝
  • 其他用途
  • 全球奥贝胆酸市场，依锭剂类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 速释片
  • 缓释片
  • 全球奥贝胆酸市场，依胶囊类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 软胶囊
  • 硬明胶胶囊
  • 全球奥贝胆酸市场，按其他产品类型细分，按类型、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 口服悬浮液
  • 注射

第七章 区域和国家分析

  • 全球奥贝胆酸市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球奥贝胆酸市场（依国家、地区、绩效及预测）2019-2024、2024-2029、2034

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 奥贝胆酸市场：竞争格局
  • 奥贝胆酸市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline（GSK）Overview, Products and Services, Strategy and Financial Analysis
    • Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Genfit Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals
  • WuXi AppTec
  • Bayer AG
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Horizon Therapeutics
  • Dr. Reddy's Laboratories
  • Lupin Limited
  • Hepalink Pharmaceutical Group5
  • Alembic Pharmaceuticals
  • Intercept Pharmaceuticals Inc.
  • Enanta Pharmaceuticals
  • Viva Life sciences
  • Omgene Life Sciences Pvt. Ltd.
  • Zydus Cadila

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年奥贝胆酸市场：提供新机会的国家
  • 2029 年奥贝胆酸市场：细分市场带来新机会
  • 2029 年奥贝胆酸市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r34643

Obeticholic acid is a medication primarily used to treat liver diseases, particularly for patients with primary biliary cholangitis (PBC), a chronic liver condition. It is a synthetic bile acid that activates a receptor called the farnesoid X receptor (FXR), which helps regulate bile acid production, liver function, and inflammation.

The main product types of obeticholic acid include tablets, capsules, and other forms. Tablets are solid dosage forms designed for convenient oral administration. The drug is distributed through various channels, such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to treat nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including the obeticholic acid industry global market size, regional shares, competitors with the obeticholic acid market share, detailed obeticholic acid segments, market trends, and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $0.90 billion in 2024 to $1.02 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth during the historic period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC), the rising incidence of non-alcoholic steatohepatitis (NASH), the expansion of healthcare infrastructure in emerging markets, higher rates of liver disease diagnostics and screening, increasing healthcare expenditure, and greater investment in liver disease research.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth during the forecast period can be attributed to the increasing prevalence of primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH), growing demand for innovative liver disease treatments, rising awareness of liver diseases and available treatments, expansion of global healthcare access in emerging markets, and increasing focus on liver disease awareness. Key trends during this period include the adoption of NASH treatments, partnerships and collaborations for further development, integration of digital health tools for monitoring and compliance, a shift toward non-alcoholic fatty liver disease (NAFLD) treatment, advancements in liver disease biomarkers, and progress in diagnostic technologies.

The increasing prevalence of liver diseases is expected to drive the growth of the obeticholic acid market. Liver diseases are conditions that impair the liver's ability to function effectively. This rise in liver diseases can be attributed to factors such as excessive alcohol consumption, which damages liver cells, leading to inflammation, cirrhosis, and eventual liver failure. Obeticholic acid aids in treating liver disease by activating the farnesoid X receptor (FXR), which helps reduce bile acid buildup, decreases inflammation, and slows fibrosis progression, thereby improving liver function. For example, in December 2024, the UK's Office for Health Improvement and Disparities reported a 3.6% increase in premature deaths from alcoholic liver disease, reaching 5,984 in 2023, up from 5,776 in 2022. This rise in liver disease cases is driving the market for obeticholic acid.

Companies operating in the obeticholic acid market are working on innovative products such as FXR agonists to improve liver disease treatment and patient outcomes. FXR agonists are compounds that activate the FXR, a receptor involved in regulating bile acid metabolism, inflammation, and fibrosis in the liver. These agonists are used to treat conditions such as primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH) and help enhance liver function. For instance, in February 2024, Intercept Pharmaceuticals Inc., a U.S.-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat PBC. The FDA's acceptance indicates progress toward validating the clinical benefits of obeticholic acid for PBC treatment.

In July 2022, Advanz Pharma Corp. Limited, a UK-based pharmaceutical company, acquired Intercept Pharmaceuticals. With this acquisition, Advanz Pharma aimed to strengthen its presence in the specialty pharmaceuticals sector by adding the commercialization rights to Ocaliva (obeticholic acid) for the treatment of PBC. Intercept Pharmaceuticals, a U.S.-based biopharmaceutical company, specializes in providing obeticholic acid.

Major players in the obeticholic acid market are Pfizer Inc., GlaxoSmithKline (GSK), Gilead Sciences Inc., Amgen Inc., Genfit, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals, WuXi AppTec, Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Dr. Reddy's Laboratories, Lupin Limited, Hepalink Pharmaceutical Group5, Alembic Pharmaceuticals, Intercept Pharmaceuticals Inc., Enanta Pharmaceuticals, Viva Life sciences, Omgene Life Sciences Pvt. Ltd., Zydus Cadila.

North America was the largest region in the Obeticholic Acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in obeticholic acid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Tablets; Capsules; Other Product Types
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
  • Sub Segments:
  • 1) By Tablets: Immediate-Release Tablets; Extended-Release Tablets
  • 2) By Capsules: Soft Gelatin Capsules; Hard Gelatin Capsules
  • 3) By Other Product Types: Oral Suspensions; Injectable Formulations
  • Companies Mentioned: Pfizer Inc.; GlaxoSmithKline (GSK); Gilead Sciences Inc.; Amgen Inc.; Genfit
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Obeticholic Acid Market Characteristics

3. Obeticholic Acid Market Trends And Strategies

4. Obeticholic Acid Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Obeticholic Acid Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Obeticholic Acid Market Growth Rate Analysis
  • 5.4. Global Obeticholic Acid Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Obeticholic Acid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Obeticholic Acid Total Addressable Market (TAM)

6. Obeticholic Acid Market Segmentation

  • 6.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • Other Product Types
  • 6.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Primary Biliary Cholangitis
  • Nonalcoholic Steatohepatitis
  • Other Applications
  • 6.4. Global Obeticholic Acid Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immediate-Release Tablets
  • Extended-Release Tablets
  • 6.5. Global Obeticholic Acid Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Soft Gelatin Capsules
  • Hard Gelatin Capsules
  • 6.6. Global Obeticholic Acid Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Suspensions
  • Injectable Formulations

7. Obeticholic Acid Market Regional And Country Analysis

  • 7.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Obeticholic Acid Market

  • 8.1. Asia-Pacific Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Obeticholic Acid Market

  • 9.1. China Obeticholic Acid Market Overview
  • 9.2. China Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Obeticholic Acid Market

  • 10.1. India Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Obeticholic Acid Market

  • 11.1. Japan Obeticholic Acid Market Overview
  • 11.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Obeticholic Acid Market

  • 12.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Obeticholic Acid Market

  • 13.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Obeticholic Acid Market

  • 14.1. South Korea Obeticholic Acid Market Overview
  • 14.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Obeticholic Acid Market

  • 15.1. Western Europe Obeticholic Acid Market Overview
  • 15.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Obeticholic Acid Market

  • 16.1. UK Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Obeticholic Acid Market

  • 17.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Obeticholic Acid Market

  • 18.1. France Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Obeticholic Acid Market

  • 19.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Obeticholic Acid Market

  • 20.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Obeticholic Acid Market

  • 21.1. Eastern Europe Obeticholic Acid Market Overview
  • 21.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Obeticholic Acid Market

  • 22.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Obeticholic Acid Market

  • 23.1. North America Obeticholic Acid Market Overview
  • 23.2. North America Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Obeticholic Acid Market

  • 24.1. USA Obeticholic Acid Market Overview
  • 24.2. USA Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Obeticholic Acid Market

  • 25.1. Canada Obeticholic Acid Market Overview
  • 25.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Obeticholic Acid Market

  • 26.1. South America Obeticholic Acid Market Overview
  • 26.2. South America Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Obeticholic Acid Market

  • 27.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Obeticholic Acid Market

  • 28.1. Middle East Obeticholic Acid Market Overview
  • 28.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Obeticholic Acid Market

  • 29.1. Africa Obeticholic Acid Market Overview
  • 29.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Obeticholic Acid Market Competitive Landscape And Company Profiles

  • 30.1. Obeticholic Acid Market Competitive Landscape
  • 30.2. Obeticholic Acid Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. GlaxoSmithKline (GSK) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Genfit Overview, Products and Services, Strategy and Financial Analysis

31. Obeticholic Acid Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Regeneron Pharmaceuticals
  • 31.3. WuXi AppTec
  • 31.4. Bayer AG
  • 31.5. Sumitomo Dainippon Pharma Co. Ltd.
  • 31.6. Horizon Therapeutics
  • 31.7. Dr. Reddy's Laboratories
  • 31.8. Lupin Limited
  • 31.9. Hepalink Pharmaceutical Group5
  • 31.10. Alembic Pharmaceuticals
  • 31.11. Intercept Pharmaceuticals Inc.
  • 31.12. Enanta Pharmaceuticals
  • 31.13. Viva Life sciences
  • 31.14. Omgene Life Sciences Pvt. Ltd.
  • 31.15. Zydus Cadila

32. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Obeticholic Acid Market

34. Recent Developments In The Obeticholic Acid Market

35. Obeticholic Acid Market High Potential Countries, Segments and Strategies

  • 35.1 Obeticholic Acid Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Obeticholic Acid Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Obeticholic Acid Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer